NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









BioSapien Inc.

BioSapien Inc.

Private
San Diego, CaliforniaHealthcare & Life Scienceshttps://biosapien.com/

Last Round

VC Round

Jul 7, 2025

Total Funding Raised

$15.31M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

BioSapien Inc. is a biotechnology company that develops 3D-printed, biodegradable mesh chips designed to deliver pharmaceuticals directly to tumor sites.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, 3D Printing, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Non-AI

Keywords

drug delivery platformbiodegradable implantlocalized chemotherapy3D-printed medical devicetargeted cancer therapyoncology devicesustained drug releaseimplantable drug deliverybiotechmedical devicedrug delivery systemsmart implantchemo implantdrug eluting meshbiomaterials

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BioSapien Inc. Comps

Public and private peers based on sector, stage, and business model.

BioSapien Inc. comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

BioSapien Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJul 7, 2025
Early FundingJan 27, 2025
Early FundingDec 12, 2024
SeedNov 11, 2021
GrantJun 30, 2021
Grant
May 1, 2021

BioSapien Inc. Investors

Notable investors and investment history

BioSapien Inc. investors
InvestorRounds
Golden Gate VenturesEarly Funding, VC Round
Global VenturesEarly Funding, VC Round
Dara HoldingsEarly Funding, VC Round
Side Door VenturesSeed
Dara ManagementEarly Funding
GlobivestVC Round
IndieBioPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 2, 2026

    Grew 30% QoQ from 10 to 13 employees.

  • Jul 7, 2025

    $1M round led by Globivest

BioSapien Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

BioSapien Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about BioSapien Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Diego, California
Employee Range13
Year Founded2018
Last FundingJul 7, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.